Income Statement EcoSynthetix Inc.

Stocks

ECO

CA27923D1087

Specialty Chemicals

Market Closed - Toronto S.E. 22:59:30 15/09/2026 +03			5-day change	1st Jan Change
2.070 ^CAD	-4.17%		-10.00%	-48.25%

07-29	EcoSynthetix Reports Q2 Net loss	MT
07-29	EcoSynthetix Inc., Q2 2026 Earnings Call, Jul 29, 2026

7702e700b05c6c1f6b76c0fafd271f2.frD7fiLNbpjFXgOtxDxm2gEMFWnRAV0ZJHy2mK0tRb4.OtrPGkOvN9-KNUrXqG0QollAXB6ObDpgXAnf6P4fDN8s3I4zR6kPq41oWg

Published financial data: ECOSYNTHETIX INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	18.16M	19.03M	12.66M	18.54M	20.8M
Total Revenues	18.16M	19.03M	12.66M	18.54M	20.8M
Cost of Goods Sold, Total	14.19M	14.88M	9.88M	13.23M	14.76M
Gross Profit	3.97M	4.15M	2.78M	5.31M	6.04M
Selling General & Admin Expenses, Total	5.53M	5.14M	4.99M	6.48M	6.2M
R&D Expenses	1.94M	1.92M	2.3M	2.01M	1.63M
Other Operating Expenses, Total	7.47M	7.06M	7.29M	8.49M	7.83M
Operating Income	-3.5M	-2.9M	-4.51M	-3.18M	-1.79M
Interest Expense, Total	-69.04K	-61.91K	-	-	-
Interest And Investment Income	131K	590K	1.18M	1.72M	1.36M
Net Interest Expenses	62.43K	528K	1.18M	1.72M	1.36M
EBT, Excl. Unusual Items	-3.44M	-2.38M	-3.33M	-1.46M	-434K
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	511K	90K	-
Other Unusual Items	256K	-	-	-	-
EBT, Incl. Unusual Items	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Earnings From Continuing Operations	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Net Income to Company	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Net Income - (IS)	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Net Income to Common Incl Extra Items	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Net Income to Common Excl. Extra Items	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Per Share Items
Net EPS - Basic	-0.06	-0.04	-0.05	-0.02	-0.01
Basic EPS - Continuing Operations	-0.06	-0.04	-0.05	-0.02	-0.01
Basic Weighted Average Shares Outstanding	57.41M	58.9M	58.93M	58.67M	58.58M
Net EPS - Diluted	-0.06	-0.04	-0.05	-0.02	-0.01
Diluted EPS - Continuing Operations	-0.06	-0.04	-0.05	-0.02	-0.01
Diluted Weighted Average Shares Outstanding	57.41M	58.9M	58.93M	58.67M	58.58M
Normalized Basic EPS	-0.04	-0.03	-0.04	-0.02	-0
Normalized Diluted EPS	-0.04	-0.03	-0.04	-0.02	-0
Supplemental Items
EBITDA	-2.46M	-1.94M	-3.52M	-2.31M	-997K
EBITA	-3.5M	-2.9M	-4.51M	-3.18M	-1.79M
EBIT	-3.5M	-2.9M	-4.51M	-3.18M	-1.79M
Normalized Net Income	-2.15M	-1.48M	-2.08M	-911K	-271K
Interest on Long-Term Debt	69.04K	61.91K	45K	26.32K	38.28K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.83M	1.92M	2.3M	2.01M	1.63M
Stock-Based Comp., SG&A Exp. (Total)	937K	-	-	-	-
Stock-Based Comp., Other (Total)	-	883K	716K	1.16M	1.04M
Total Stock-Based Compensation	937K	883K	716K	1.16M	1.04M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	42.23M	4.81M	4.92M	7.72M	8.42M
Short Term Investments	-	21.05M	28.37M	24.47M	21.16M
Total Cash And Short Term Investments	42.23M	25.86M	33.28M	32.2M	29.58M
Accounts Receivable, Total	1.72M	2.27M	1.11M	1.99M	2.93M
Other Receivables	203K	664K	441K	333K	307K
Total Receivables	1.92M	2.93M	1.55M	2.33M	3.23M
Inventory	2.07M	5.32M	3.64M	2.83M	3.77M
Prepaid Expenses	91.93K	85.13K	91.92K	90.31K	204K
Total Current Assets	46.31M	34.2M	38.57M	37.44M	36.79M
Gross Property Plant And Equipment	18.92M	18.84M	18.82M	17.38M	19.69M
Accumulated Depreciation	-14.25M	-14.98M	-14.55M	-13.54M	-13.75M
Net Property Plant And Equipment	4.67M	3.86M	4.27M	3.85M	5.94M
Long-term Investments	-	10.14M	-	-	-
Total Assets	50.98M	48.19M	42.84M	41.28M	42.73M
Liabilities
Accounts Payable, Total	960K	1.26M	831K	729K	770K
Accrued Expenses, Total	1.15M	1.06M	450K	972K	1.18M
Current Portion of Leases	256K	276K	326K	238K	405K
Total Current Liabilities	2.36M	2.6M	1.61M	1.94M	2.36M
Long-Term Leases	820K	544K	258K	-	1.79M
Total Liabilities	3.18M	3.14M	1.87M	1.94M	4.14M
Common Stock, Total	492M	492M	490M	489M	489M
Additional Paid In Capital	9.85M	10.08M	10.25M	11.01M	11.21M
Retained Earnings	-454M	-457M	-460M	-461M	-461M
Total Common Equity	47.8M	45.06M	40.97M	39.35M	38.59M
Total Equity	47.8M	45.06M	40.97M	39.35M	38.59M
Total Liabilities And Equity	50.98M	48.19M	42.84M	41.28M	42.73M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	58.96M	59.27M	58.61M	58.53M	59.06M
ECS Total Common Shares Outstanding	58.93M	59.26M	58.66M	58.52M	58.49M
Book Value / Share	0.81	0.76	0.7	0.67	0.66
Tangible Book Value	47.8M	45.06M	40.97M	39.35M	38.59M
Tangible Book Value Per Share	0.81	0.76	0.7	0.67	0.66
Total Debt	1.08M	819K	584K	238K	2.19M
Net Debt	-41.15M	-25.04M	-32.7M	-31.96M	-27.39M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.02M	2.47M	846K	629K	1.62M
Inventories - Finished Goods, Total	1.06M	2.85M	2.8M	2.2M	2.14M
Machinery, Total	16.43M	16.28M	17.06M	15.62M	15.67M
Full Time Employees	26	26	25	28	28

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-3.18M	-2.38M	-2.82M	-1.37M	-434K
Depreciation & Amortization - CF	1.29M	1.23M	1.26M	1.15M	1.13M
Depreciation & Amortization, Total	1.29M	1.23M	1.26M	1.15M	1.13M
(Gain) Loss From Sale Of Asset	-	-	-511K	-90K	-
Stock-Based Compensation (CF)	937K	883K	716K	1.16M	1.04M
Other Operating Activities, Total	497K	-614K	-327K	-338K	113K
Change In Accounts Receivable	-273K	-1M	1.38M	-776K	-910K
Change In Inventories	-31.62K	-3.15M	1.67M	825K	-977K
Change In Accounts Payable	1.14M	131K	-1.05M	536K	124K
Change in Other Net Operating Assets	93.24K	-4.91K	-6.79K	1.61K	-114K
Cash from Operations	474K	-4.9M	317K	1.1M	-23.54K
Capital Expenditure	-380K	-273K	-1.63M	-868K	-846K
Sale of Property, Plant, and Equipment	-	-	511K	90K	-
Investment in Marketable and Equity Securities, Total	25M	-30.88M	3.11M	4.25M	3.02M
Other Investing Activities, Total	67.42K	-	-	-	-
Cash from Investing	24.69M	-31.15M	2M	3.47M	2.18M
Long-Term Debt Repaid, Total	-249K	-264K	-288K	-317K	-320K
Total Debt Repaid	-249K	-264K	-288K	-317K	-320K
Issuance of Common Stock	1.92M	972K	431K	760K	43.24K
Repurchase of Common Stock	-1.2M	-2.22M	-2.41M	-2.18M	-1.41M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	474K	-1.51M	-2.27M	-1.73M	-1.69M
Foreign Exchange Rate Adjustments	-46.13K	146K	62.37K	-37.48K	232K
Net Change in Cash	25.59M	-37.42M	107K	2.81M	699K
Supplemental Items
Levered Free Cash Flow	820K	-4.05M	-453K	-84.74K	-1.51M
Unlevered Free Cash Flow	863K	-4.01M	-453K	-84.74K	-1.51M
Change In Net Working Capital	-1.2M	4.04M	-2.01M	-460K	1.71M
Net Debt Issued / Repaid	-249K	-264K	-288K	-317K	-320K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-4.26	-3.66	-6.19	-4.73	-2.67
Return on Total Capital	-4.39	-3.83	-6.44	-4.9	-2.79
Return On Equity %	-6.54	-5.12	-6.56	-3.4	-1.11
Return on Common Equity	-6.54	-5.12	-6.56	-3.4	-1.11
Margin Analysis
Gross Profit Margin %	21.87	21.82	21.97	28.63	29.02
SG&A Margin	30.46	26.98	39.39	34.95	29.82
EBITDA Margin %	-13.53	-10.17	-27.83	-12.45	-4.79
EBITA Margin %	-19.26	-15.25	-35.61	-17.16	-8.63
EBIT Margin %	-19.26	-15.25	-35.61	-17.16	-8.63
Income From Continuing Operations Margin %	-17.51	-12.48	-22.28	-7.37	-2.09
Net Income Margin %	-17.51	-12.48	-22.28	-7.37	-2.09
Net Avail. For Common Margin %	-17.51	-12.48	-22.28	-7.37	-2.09
Normalized Net Income Margin	-11.82	-7.8	-16.45	-4.91	-1.3
Levered Free Cash Flow Margin	4.51	-21.26	-3.58	-0.46	-7.25
Unlevered Free Cash Flow Margin	4.75	-21.06	-3.58	-0.46	-7.25
Asset Turnover
Asset Turnover	0.35	0.38	0.28	0.44	0.5
Fixed Assets Turnover	3.53	4.46	3.11	4.57	4.25
Receivables Turnover (Average Receivables)	11.18	9.56	7.5	11.95	8.45
Inventory Turnover (Average Inventory)	6.74	4.03	2.2	4.09	4.48
Short Term Liquidity
Current Ratio	19.59	13.18	24	19.31	15.62
Quick Ratio	18.68	11.09	21.67	17.8	13.93
Operating Cash Flow to Current Liabilities	0.2	-1.89	0.2	0.57	-0.01
Days Sales Outstanding (Average Receivables)	32.65	38.18	48.65	30.62	43.18
Days Outstanding Inventory (Average Inventory)	54.12	90.65	165.55	89.52	81.55
Average Days Payable Outstanding	19.63	22.36	46.55	23	17.43
Cash Conversion Cycle (Average Days)	67.14	106.47	167.65	97.14	107.31
Long Term Solvency
Total Debt/Equity	2.25	1.82	1.43	0.6	5.68
Total Debt / Total Capital	2.2	1.79	1.41	0.6	5.38
LT Debt/Equity	1.72	1.21	0.63	-	4.63
Long-Term Debt / Total Capital	1.68	1.18	0.62	-	4.38
Total Liabilities / Total Assets	6.24	6.51	4.35	4.7	9.69
EBIT / Interest Expense	-50.67	-46.9	-	-	-
EBITDA / Interest Expense	-32.01	-26.99	-	-	-
(EBITDA - Capex) / Interest Expense	-37.51	-31.4	-	-	-
Total Debt / EBITDA	-0.49	-0.49	-0.18	-0.12	-3.31
Net Debt / EBITDA	18.62	14.99	10.08	15.76	41.29
Total Debt / (EBITDA - Capex)	-0.42	-0.42	-0.12	-0.08	-1.45
Net Debt / (EBITDA - Capex)	15.89	12.88	6.71	11.03	18.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.93	4.8	-33.49	46.42	12.19
Gross Profit, 1 Yr. Growth %	45.04	4.59	-33.03	90.78	13.73
EBITDA, 1 Yr. Growth %	9.64	-12.08	81.99	-34.5	-56.8
EBITA, 1 Yr. Growth %	1.14	-10.45	55.26	-29.42	-43.6
EBIT, 1 Yr. Growth %	1.14	-10.45	55.26	-29.42	-43.6
Earnings From Cont. Operations, 1 Yr. Growth %	32.37	-25.3	18.77	-51.55	-68.26
Net Income, 1 Yr. Growth %	32.37	-25.3	18.77	-51.55	-68.26
Normalized Net Income, 1 Yr. Growth %	20.42	-25.3	40.28	-56.28	-70.23
Diluted EPS Before Extra, 1 Yr. Growth %	31.88	-27.19	18.71	-51.33	-68.22
Accounts Receivable, 1 Yr. Growth %	12	32.03	-51.07	79.69	46.97
Inventory, 1 Yr. Growth %	-2.84	156.41	-31.49	-22.35	33.19
Net Property, Plant and Equip., 1 Yr. Growth %	-16.91	-17.36	10.61	-9.93	54.57
Total Assets, 1 Yr. Growth %	-1.43	-5.47	-11.12	-3.62	3.5
Tangible Book Value, 1 Yr. Growth %	-3.38	-5.74	-9.07	-3.96	-1.92
Common Equity, 1 Yr. Growth %	-3.38	-5.74	-9.07	-3.96	-1.92
Cash From Operations, 1 Yr. Growth %	109.05	-1.13K	-106.47	248.45	-102.13
Capital Expenditures, 1 Yr. Growth %	53.13	-28.15	495.71	-46.6	-2.55
Levered Free Cash Flow, 1 Yr. Growth %	-402.01	-513.05	-88.69	-81.31	1.68K
Unlevered Free Cash Flow, 1 Yr. Growth %	-484.64	-491.84	-88.69	-81.31	1.68K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.78	18.03	-16.51	-1.32	28.17
Gross Profit, 2 Yr. CAGR %	-0.72	23.17	-16.31	13.03	47.3
EBITDA, 2 Yr. CAGR %	32.54	-7.07	26.49	9.18	-46.81
EBITA, 2 Yr. CAGR %	16.83	-8.38	17.91	4.68	-36.91
EBIT, 2 Yr. CAGR %	16.83	-8.38	17.91	4.68	-36.91
Earnings From Cont. Operations, 2 Yr. CAGR %	47.88	-0.56	-5.81	-24.14	-60.79
Net Income, 2 Yr. CAGR %	47.88	-0.56	-5.81	-24.14	-60.79
Normalized Net Income, 2 Yr. CAGR %	53.71	-8.76	2.37	-21.68	-63.92
Diluted EPS Before Extra, 2 Yr. CAGR %	49.02	-2.01	-7.03	-23.99	-60.67
Accounts Receivable, 2 Yr. CAGR %	3.24	21.6	-19.62	-6.23	62.51
Inventory, 2 Yr. CAGR %	-4.4	57.84	32.54	-27.06	1.7
Net Property, Plant and Equip., 2 Yr. CAGR %	-16.69	-17.14	-4.39	-0.19	17.99
Total Assets, 2 Yr. CAGR %	-3.47	-3.47	-8.34	-7.45	-0.12
Tangible Book Value, 2 Yr. CAGR %	-4.28	-4.57	-7.42	-6.55	-2.95
Common Equity, 2 Yr. CAGR %	-4.28	-4.57	-7.42	-6.55	-2.95
Cash From Operations, 2 Yr. CAGR %	-18.03	364.64	-18.23	-52.5	-72.75
Capital Expenditures, 2 Yr. CAGR %	-8.93	4.89	106.89	78.35	-27.87
Levered Free Cash Flow, 2 Yr. CAGR %	241.19	286.11	-31.97	-85.46	82.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	250.05	322.68	-33.42	-85.46	82.37
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.3	1.05	-2.51	0.68	3
Gross Profit, 3 Yr. CAGR %	-4.05	1.02	0.53	10.14	13.26
EBITDA, 3 Yr. CAGR %	7.36	11.43	16.26	1.58	-19.85
EBITA, 3 Yr. CAGR %	2.64	4.25	9.23	-0.63	-14.82
EBIT, 3 Yr. CAGR %	2.64	4.25	9.23	-0.63	-14.82
Earnings From Cont. Operations, 3 Yr. CAGR %	7.91	17.77	5.51	-24.53	-43.26
Net Income, 3 Yr. CAGR %	7.91	17.77	5.51	-24.53	-43.26
Normalized Net Income, 3 Yr. CAGR %	14.18	17.77	5.31	-22.91	-43.26
Diluted EPS Before Extra, 3 Yr. CAGR %	9.2	17.37	4.46	-25.07	-43.16
Accounts Receivable, 3 Yr. CAGR %	-6.67	12.06	-10.23	5.1	8.92
Inventory, 3 Yr. CAGR %	-8.68	32.83	19.51	10.9	-10.85
Net Property, Plant and Equip., 3 Yr. CAGR %	-8.89	-16.92	-8.76	-6.27	15.48
Total Assets, 3 Yr. CAGR %	-3.29	-4.14	-6.09	-6.79	-3.93
Tangible Book Value, 3 Yr. CAGR %	-4.05	-4.77	-6.09	-6.28	-5.03
Common Equity, 3 Yr. CAGR %	-4.05	-4.77	-6.09	-6.28	-5.03
Cash From Operations, 3 Yr. CAGR %	-37.39	90.73	11.81	32.57	-83.12
Capital Expenditures, 3 Yr. CAGR %	20.19	-15.85	87.15	31.72	45.81
Levered Free Cash Flow, 3 Yr. CAGR %	-14.24	285.89	18.65	-55.78	-27.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.76	284.66	26.44	-56.41	-27.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.47	1.25	-11.1	0.1	8.77
Gross Profit, 5 Yr. CAGR %	12.53	2.51	-9.16	5.66	17.13
EBITDA, 5 Yr. CAGR %	-20.89	-19.75	12.15	10.53	-14.96
EBITA, 5 Yr. CAGR %	-17.71	-16.25	6.86	4.42	-12.3
EBIT, 5 Yr. CAGR %	-17.71	-16.25	6.86	4.42	-12.3
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.33	-18.09	2.2	-1.23	-28.99
Net Income, 5 Yr. CAGR %	-19.33	-18.09	2.2	-1.23	-28.99
Normalized Net Income, 5 Yr. CAGR %	-17.09	-17.93	7.62	0.04	-31.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-18.8	-17.91	2.39	-1.35	-29.33
Accounts Receivable, 5 Yr. CAGR %	-2.17	2.4	-12.08	4.35	13.83
Inventory, 5 Yr. CAGR %	-8.4	15.97	6	4.51	12.04
Net Property, Plant and Equip., 5 Yr. CAGR %	-10.06	-11.52	-7.12	-10.59	1.12
Total Assets, 5 Yr. CAGR %	-5.39	-4.72	-5.34	-5.48	-3.75
Tangible Book Value, 5 Yr. CAGR %	-5.6	-5.06	-5.41	-5.49	-4.85
Common Equity, 5 Yr. CAGR %	-5.6	-5.06	-5.41	-5.49	-4.85
Cash From Operations, 5 Yr. CAGR %	-43.03	2.05	-30.33	9.38	-36.43
Capital Expenditures, 5 Yr. CAGR %	-8.26	-5.39	49.35	13.64	27.81
Levered Free Cash Flow, 5 Yr. CAGR %	-26.31	12.65	-18.99	3.77	40.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-25.55	12.43	-18.99	3.77	46.39